Purchase Order N0018319P0631
Award Date 6/25/19
Potential Completion Date 9/30/20
Potential Value $88K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
- This is a firm fixed price contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 molecular testing services. The contract has a potential value of $395,000.00 and a completion date of December 15, 2020. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next generation genomic...
- This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of TYROSEQ V.2 MOLECULAR TESTING services. The $150,000.00 firm fixed price purchase order was issued by the Defense Health Agency and does not have a set-aside designation. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next generation genomic sequencing under...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
- This federal contract award is for $78,750.00 to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for THYROSEQ GENOMIC TESTING services. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6 (VISN 6). The contract has an ultimate completion date of September 30, 2026 and was awarded on October 1, 2025. Cytopath Biopsy Lab Inc. is...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6. The contract, with a ceiling value of $45,000.00, is for the company's proprietary ThyroSeq genomic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of September...
- This is a firm fixed price purchase order awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 MOLECULAR TESTING services. The contract has a completion date of September 30, 2017 and a potential value of $150,000.00. Cblpath is a for-profit organization that provides specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next-generation...
- This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
- This is a contract award to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Defense Health Agency for ThyroSeq genetic testing services. Cytopath Biopsy Lab is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next-generation genomic sequencing. The $148,142.40 firm fixed price contract is for the provision of ThyroSeq testing, which involves analyzing genetic mutations to evaluate the...